Janney Montgomery Scott LLC reduced its position in Mylan N.V. (NASDAQ:MYL) by 24.3% during the second quarter, Holdings Channel reports. The fund owned 26,162 shares of the company’s stock after selling 8,400 shares during the period. Janney Montgomery Scott LLC’s holdings in Mylan N.V. were worth $1,016,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the company. Harbour Capital Advisors LLC boosted its stake in shares of Mylan N.V. by 3,782.2% in the second quarter. Harbour Capital Advisors LLC now owns 8,735 shares of the company’s stock worth $225,000 after buying an additional 8,510 shares during the last quarter. IBM Retirement Fund boosted its stake in shares of Mylan N.V. by 155.7% in the second quarter. IBM Retirement Fund now owns 13,045 shares of the company’s stock worth $566,000 after buying an additional 7,943 shares during the last quarter. NGAM Advisors L.P. boosted its stake in shares of Mylan N.V. by 18.0% in the second quarter. NGAM Advisors L.P. now owns 46,705 shares of the company’s stock worth $1,813,000 after buying an additional 7,123 shares during the last quarter. Sumitomo Life Insurance Co. boosted its stake in shares of Mylan N.V. by 135.0% in the second quarter. Sumitomo Life Insurance Co. now owns 36,711 shares of the company’s stock worth $1,425,000 after buying an additional 21,087 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. boosted its stake in shares of Mylan N.V. by 15.0% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 25,986 shares of the company’s stock worth $1,009,000 after buying an additional 3,398 shares during the last quarter. Institutional investors and hedge funds own 70.19% of the company’s stock.

Shares of Mylan N.V. (NASDAQ:MYL) opened at 30.88 on Friday. The stock has a 50 day moving average price of $37.34 and a 200 day moving average price of $39.01. Mylan N.V. has a 1-year low of $29.58 and a 1-year high of $49.42. The company has a market capitalization of $16.56 billion, a price-to-earnings ratio of 24.96 and a beta of 1.27.

Mylan N.V. (NASDAQ:MYL) last posted its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.18 by $0.08. The company had revenue of $2.96 billion during the quarter, compared to analysts’ expectations of $3 billion. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. Mylan N.V.’s revenue for the quarter was up 15.7% on a year-over-year basis. During the same quarter last year, the company earned $1.16 earnings per share. On average, equities analysts anticipate that Mylan N.V. will post $4.68 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright legislation. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/13/janney-montgomery-scott-llc-has-1-02-million-stake-in-mylan-n-v-myl.html.

A number of analysts have commented on the company. UBS AG restated a “buy” rating and issued a $46.00 price target (down previously from $50.00) on shares of Mylan N.V. in a research report on Thursday. BMO Capital Markets restated an “outperform” rating and issued a $45.00 price target (down previously from $50.00) on shares of Mylan N.V. in a research report on Thursday. Royal Bank Of Canada reiterated a “sector perform” rating and set a $32.00 target price (down previously from $33.00) on shares of Mylan N.V. in a research report on Thursday. Cowen and Company reiterated a “hold” rating and set a $30.00 target price (down previously from $43.00) on shares of Mylan N.V. in a research report on Wednesday. Finally, Cantor Fitzgerald set a $34.00 target price on Mylan N.V. and gave the stock a “hold” rating in a research report on Wednesday. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. Mylan N.V. presently has an average rating of “Buy” and an average price target of $47.83.

In other news, President Rajiv Malik sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $40.00, for a total value of $1,000,000.00. Following the completion of the sale, the president now directly owns 799,855 shares in the company, valued at $31,994,200. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Anthony Mauro sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $400,000.00. Following the completion of the sale, the insider now owns 140,653 shares of the company’s stock, valued at $5,626,120. The disclosure for this sale can be found here. 0.69% of the stock is owned by corporate insiders.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.